Triple-Negative Breast Cancer (TNBC) Completed Phase 1 Trials for Veliparib (DB07232)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01104259Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast CancerTreatment